 产品搜索 |
| 产品类别 |
| 推荐产品 |
 叔丁基二甲基氯硅烷 |
| 2-氯-4,6-二甲基吡啶 |
| 2-溴-4,6-二甲基吡啶 |
| 6-氯苯并三氮唑-1,1,3,3- |
| 1,3-二苯基异苯并呋喃 |
| 培哚普利 |
| 9-(4-乙酰氧基-3-乙酰氧 |
| 嘧啶-5-硼酸 |
| 2-氯-3-硝基-4-甲基吡啶 |
| 7-氮杂吲哚 |
| 4-氮杂吲哚 |
| 5-氮杂吲哚 |
| 6-氮杂吲哚 |
| 7-azaoxindole |
| 6-azaoxindole |
| 4-叔丁基苯硼酸 |
| D-氨基半乳糖盐酸盐 |
| N-乙酰基-D-氨基半乳糖 |
| 溴代葡萄糖苷 |
| 利培酮 |
| N-三氟乙酰基-L-赖氨酸 |
| N2-(1-乙氧羰基-3-苯丙基 |
| N2-[1-(S)-乙氧羰基-3-苯 |
| 3-氨基甲酰基苯硼酸 |
| 2,4-二氯-6-甲基嘧啶 |
| N-(4-氨基丁基)-N-乙基异 |
| AOP |
| BOP |
| 4,4-二甲氧基三苯甲基 |
| 2-氯-1-甲基吡啶碘盐 |
| HOTT |
| TSTU |
| 1-(4-甲磺基)-3-硝基-1,2,4 |
| TPTU |
| 2,4,6-三异丙基苯磺酰氯 |
| TOTU |
| TOTT |
| TNTU |
| TFFH |
| TDBTU |
| TCTU |
| TCFH |
| TBTU |
| TATU |
| N-Hydroxysulfosuccinimide sodi |
| 8-喹啉磺酰氯 |
| PyCloP |
| PYCLU |
| PyBroP |
| PyBOP |
|
| 产品展示 |
| 产品编号 |
产品名称 |
CAS No. |
含量 |
| G77485 | N-[(6-Chloro-3-pyridyl)methyl]-2,2-dimethoxyethanamine | 1509093-27-9 | 95% |
| G77486 | 2-[1-Methyl-5-(trifluoromethyl)pyrazol-4-yl]acetic acid | 1515490-32-0 | 95% |
| G77487 | N-[[4-Fluoro-2-(trifluoromethyl)phenyl]methyl]-N-methylpyrrolidin-3-amine | 1517304-37-8 | 95% |
| G77488 | N-(6-Bromo-3-pyridinyl)-2-chloroacetamide | 1528450-67-0 | 95% |
| G77489 | 6-(2-Pyrazinyl)-3-pyridinamine | 1556886-12-4 | 95% |
| G77490 | 6-(Trifluoromethyl)-3-pyridazineacetic acid | 1565408-90-3 | 95% |
| G77491 | tert-Butyl 4-[[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl]-1,4-diazepane-1-carboxylate | 1638523-07-5 | 95% |
| G77492 | 3-Methyl-4-[[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl]morpholine | 1638523-15-5 | 95% |
| G77493 | 2-Methyl-4-[[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl]morpholine | 1638523-17-7 | 95% |
| G77494 | 2,3-Dimethyl-4-[[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl]morpholine | 1638523-21-3 | 95% |
| G77495 | 2,5-Dimethyl-4-[[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl]morpholine | 1638523-23-5 | 95% |
| G77496 | 2,2-Dimethyl-4-[[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl]morpholine | 1638523-25-7 | 95% |
| G77497 | 2,6-Dimethyl-4-[[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl]morpholine | 1638523-31-5 | 95% |
| G77498 | 3-[[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl]-8-oxa-3-azabicyclo[3.2.1]octane | 1638523-33-7 | 95% |
| G77499 | 2-[[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline | 1638523-48-4 | 95% |
| G77500 | 1-[(5-Bromo-2-pyridyl)methyl]-3,4-dihydro-2H-quinoline | 1638523-90-6 | 95% |
| G77501 | 3-[[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl]-1,2,4,5-tetrahydro-3-benzazepine | 1638524-00-1 | 95% |
| G77502 | 2-[[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl]-1,3,4,5-tetrahydro-2-benzazepine | 1638524-02-3 | 95% |
| G77503 | 1-[[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl]indoline | 1638524-06-7 | 95% |
| G77504 | 2-[[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl]isoindoline | 1638524-71-6 | 95% |
| G77505 | N-(1-benzylpiperidin-4-yl)-6-chloro-N,4,5-trimethylpyridazin-3-amine | 1643666-07-2 | 95% |
| G77506 | N-[2-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-2,2-dimethylpropanamide | 1662682-31-6 | 95% |
| G77507 | N-(3-Bromo-2-fluorophenyl)-2,2-dimethylpropanamide | 1662682-32-7 | 95% |
| G77508 | 3-Methoxy-1-[(4-methoxyphenyl)methyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole | 1662682-34-9 | 95% |
| G77509 | 1-Benzyl-3-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole | 1662682-36-1 | 95% |
| G77510 | 2-Methyl-3-methylsulfanyl-4-(trifluoromethyl)benzaldehyde | 1679326-11-4 | 95% |
| G77511 | 2-(2-Methyl-1-oxoisoindolin-5-yl)acetic acid | 1781080-51-0 | 95% |
| G77512 | 2-(4-tert-Butylpyrazol-1-yl)acetic acid | 1784054-43-8 | 95% |
| G77513 | 2-(5-Methoxypyridin-2-yl)acetic acid hydrochloride | 1798730-78-5 | 95% |
| G77514 | 2-(3-Fluoro-5-methyl-2-pyridyl)acetic acid | 1804047-89-9 | 95% |
|
|
|
|
